Dr. Samuel J. Kerr

Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is rated as an Elite provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, and Brain Tumor.

Arati Desai is an Oncologist in Philadelphia, Pennsylvania. Dr. Desai is rated as an Elite provider by MediFind in the treatment of Posterior Fossa Tumor. Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri. Dr. Desai is currently accepting new patients.

Philosophy of care | In my area we’re dealing with people who are frightened. I’m trying to help patients deal with all of the information they’ve been hearing, and I’m trying to dispel all of the myths. It’s a matter of education and mutual trust. I’m there to do whatever I can do for them, even if it’s just a matter of easing their pain. | Also, I am a member of the thoracic cancer multidisciplinary consultation team. Together we review your diagnostic information and give you a written opinion reflecting the scope of your condition and recommendations for your best course of care. | Why I entered medicine | Medicine was not my first choice. I wanted to be first oboe in the New York Philharmonic. I have a love of biochemistry and science, and I like people. One day, I just decided I wanted to be a doctor. I wouldn’t change it for anything in the world. | Community involvement | I’m part of the National Cancer Institute’s community cancer program. Our goal is to be able to give the same care and treatment to everyone, whether they have health insurance or not. | Personal interests | I still play the oboe and will always have a love of music. I’m an avid cyclist, and I enjoy skiing. Dr. Friedman is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and Bone Marrow Aspiration.